Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas
Downloads News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Ajanta Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 532331 border-img ISIN Demat INE031B01049 border-img Book Value 290.22 border-img NSE Symbol AJANTPHARM border-img Div & Yield % 1.11 border-img Market Cap (₹ Cr.) 31539.68 border-img P/E 34.81 border-img EPS 72.53 border-img Face Value 2
ParticularsMar 2025
(₹)		Mar 2024
(₹)		Mar 2023
(₹)		Mar 2022
(₹)		Mar 2021
(₹)		Mar 2020
(₹)
INCOME :       
Sales Turnover 4322.043971.123411.273140.642718.592196.42
Excise Duty 0.000.000.000.000.000.00
Net Sales 4322.043971.123411.273140.642718.592196.42
Other Income 119.87116.48132.75139.73103.57184.20
Stock Adjustments 18.5822.1721.9956.6074.60-9.02
Total Income 4460.494109.773566.013336.972896.762371.60
EXPENDITURE :       
Raw Materials 1030.601101.591027.40889.16804.68654.95
Power & Fuel Cost 70.2266.4465.5354.0943.4238.56
Employee Cost 1010.90834.16720.41585.87498.11437.82
Other Manufacturing Expenses 198.94168.11185.50169.95119.25124.80
Selling & Administrative Expenses 695.46587.02602.95512.46324.31308.60
Miscellaneous Expenses 129.78116.54132.1994.8286.5193.81
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 3135.902873.862733.982306.351876.281658.54
Operating Profit 1324.591235.91832.031030.621020.48713.06
Interest 4.606.805.239.126.909.10
Gross Profit 1319.991229.11826.801021.501013.58703.96
Depreciation 139.93132.16126.95120.96111.4991.29
Profit Before Tax 1180.061096.95699.85900.54902.09612.67
Tax 258.03280.56141.08171.17216.68168.09
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 5.149.150.059.519.773.45
Reported Net Profit 916.89807.24558.72719.86675.64441.13
Extraordinary Items 10.8811.1112.87-0.622.91-2.89
Adjusted Net Profit 906.01796.13545.85720.48672.73444.02
Adjustment below Net Profit -213.11-0.92-74.72-68.50-32.42-3.85
P & L Balance brought forward 3253.443089.292694.982125.831565.511244.15
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 349.75642.1789.6982.2182.90115.93
P & L Balance carried down 3607.473253.443089.292694.982125.831565.50
Dividend 349.75642.1789.6982.2182.90113.44
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 1400.002550.00350.00475.00475.00650.00
Dividend Per Share(Rs) 28.0051.007.009.509.5013.00
Earnings Per Share-Unit Curr 73.1563.8944.2283.8577.7050.30
Earnings Per Share(Adj)-Unit Curr 73.1563.8944.2255.9051.8033.53
Book Value-Unit Curr 289.21270.17256.94369.15331.80280.65
Book Value(Adj)-Unit Curr 289.21270.17256.94246.10221.20187.10

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

25th ANNIVERSARY 

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109, |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh